With another phase 3 win, Gilead races toward 2025 launch for long-acting PrEP drug zbecker Thu, 09/12/2024 – 11:15 More: With another phase 3 win, Gilead races toward 2025 launch for long-acting PrEP drug Source: fierce
read moreSanofi completes build out of $554M pandemic-ready modular plant for vaccines, biologics kdunleavy Thu, 09/12/2024 – 10:01 More: Sanofi completes build out of 4M pandemic-ready modular plant for vaccines, biologics Source: fierce
read moreBavarian Nordic eyes external partnerships in bid to produce tens of millions of mpox vaccine doses fkansteiner Thu, 09/12/2024 – 09:40 More: Bavarian Nordic eyes external partnerships in bid to produce tens of millions of mpox vaccine doses Source: fierce
read more
New study highlights potential benefits of menopausal hormone therapy More: HRT linked to reduced psychosis relapse risk in menopausal women Source: News
read more
Promising results for novel orexin agonist in sleep-deprived volunteers More: Centessa reports positive phase 1 clinical data for ORX750 Source: News
read moreFDA slams AbbVie for misleading claims in Serena Williams ad for migraine drug Ubrelvy ntaylor Thu, 09/12/2024 – 06:49 More: FDA slams AbbVie for misleading claims in Serena Williams ad for migraine drug Ubrelvy Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals